GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galectin Therapeutics Inc (STU:PHPN) » Definitions » Price-to-Tangible-Book

Galectin Therapeutics (STU:PHPN) Price-to-Tangible-Book : (As of Jun. 11, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Galectin Therapeutics Price-to-Tangible-Book?

As of today (2024-06-11), Galectin Therapeutics's share price is €2.44. Galectin Therapeutics's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €-1.09. Hence, Galectin Therapeutics's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Galectin Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Galectin Therapeutics's highest Price to Tangible Book Ratio was 345.00. The lowest was 2.71. And the median was 5.18.

STU:PHPN's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.77
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Galectin Therapeutics's share price is €2.44. Galectin Therapeutics's Book Value per Sharefor the quarter that ended in Mar. 2024 was €-1.09. Hence, Galectin Therapeutics's P/B Ratio of today is .


Galectin Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Galectin Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galectin Therapeutics Price-to-Tangible-Book Chart

Galectin Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 5.73 380.00 - -

Galectin Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Galectin Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Galectin Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galectin Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galectin Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Galectin Therapeutics's Price-to-Tangible-Book falls into.



Galectin Therapeutics Price-to-Tangible-Book Calculation

Galectin Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=2.44/-1.085
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Galectin Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Galectin Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Galectin Therapeutics (STU:PHPN) Business Description

Traded in Other Exchanges
Address
4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA, USA, 30071
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Galectin Therapeutics (STU:PHPN) Headlines

No Headlines